Nucleic Acid Testing to Reduce the Possible Risk of Parvovirus B19 Transmission by Plasma-Derived Products: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 28, 2009
May 15, 2019
61270a0b-4323-4d9d-8dab-c2b9ea3aaf2c
Related Documents
Clinical Considerations for Therapeutic Cancer Vaccines: Guidance for Industry
Guidance DocumentOctober 1, 2011Center for Biologics Evaluation and Research
Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion: Guidance for Industry
Guidance DocumentNovember 6, 2009Center for Biologics Evaluation and Research
Preclinical Assessment of Investigational Cellular and Gene Therapy Products: Guidance for Industry
Guidance DocumentNovember 1, 2013Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox